Identification of unique truncated KC/GROβ chemokines with potent hematopoietic and anti-infective activities

Andrew G. King, Kyung Johanson, Carrie L. Frey, Peter L. Demarsh, John R. White, Patrick McDevitt, Dean McNulty, Joanna Balcarek, Zdenka L. Jonak, Pradip K. Bhatnagar, Louis M. Pelus

Research output: Contribution to journalArticle

37 Scopus citations

Abstract

SK and F 107647, a previously described synthetic immunomodulatory peptide, indirectly stimulates bone marrow progenitor cells and phagocytic cells, and enhances host defense effector mechanisms in bacterial and fungal infection models in vivo. In vitro, SK and F 107647 induces the production of a soluble mediator that augments colony forming cell (CFU-GM) formation in the presence of CSFs. In this paper we purified and sequenced the stromal cell-derived hematopoietic synergistic factors (HSF) secreted from both murine and human cell lines stimulated with SK and F 107647. Murine HSF is an N-terminal 4-aa truncated form of the CXC chemokine, KC, while human HSF was identified as an N-terminal 4-aa truncated form of the CXC chemokine, GROβ. In comparison to their full-length forms, truncated KC and truncated GROβ were 10 million times more potent as synergistic growth stimulants for CFU- GM. Enhanced potency of these novel truncated chemokines relative to their full-length forms was also demonstrated in respiratory burst assays, CD11b Ag expression, and intracellular killing of the opportunistic pathogen, Candida albicans. Administration of truncated KC significantly enhanced survival of mice lethally infected with C. albicans. The results reported herein delineate the biological mechanism of action of SK and F 107647, which functions via the induction of unique specific truncated forms of the chemokines KC and GROβ. To our knowledge, this represents the first example where any form of KC or GROβ were purified from marrow stromal cells. Additionally, this is the first demonstration of in vivo efficacy of a CXC chemokine in an animal infectious fungal disease model.

Original languageEnglish (US)
Pages (from-to)3774-3782
Number of pages9
JournalJournal of Immunology
Volume164
Issue number7
StatePublished - Apr 1 2000

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Identification of unique truncated KC/GROβ chemokines with potent hematopoietic and anti-infective activities'. Together they form a unique fingerprint.

  • Cite this

    King, A. G., Johanson, K., Frey, C. L., Demarsh, P. L., White, J. R., McDevitt, P., McNulty, D., Balcarek, J., Jonak, Z. L., Bhatnagar, P. K., & Pelus, L. M. (2000). Identification of unique truncated KC/GROβ chemokines with potent hematopoietic and anti-infective activities. Journal of Immunology, 164(7), 3774-3782.